Ono Pharmaceutical Co. Ltd., an Osaka, Japan-based pharmaceutical company. expanded investment in Ono Venture Investment Fund I, L.P. from US$100M to US$200M.
Established as a corporate venture capital fund in South San Francisco, CA, USA in May 2020, Ono Venture Investment manages the investment fund and invests in bio-ventures and startup companies.
Since the establishment in 2020, OVI have been supporting the drug discovery activities through strategic investments in 11 bio-venture companies to date, including the most recent investment in Photys Therapeutics (Waltham, MA, USA).
Led by President and CEO Gyo Sagara, Ono Pharmaceutical aims of accessing and partnering on drug discovery targets and technologies for the generation of innovative medicines.